Skip to main content

Week in Review - 20 Feb 2016

  1. Dr. Jeff Curtis: blog on why  some patients don't/won't do T2T and how to best frame the need for T2T in RA https://t.co/E4COzfBg0H
  2. Poor outcomes in spondyloarthritis  due to: age >33yr, low education level, smoking, high baseline BASDAI and not meeting ASAS criteria
  3. IL-36 is an important mediator of bowel inflammation in mouse model of IBD, Blocking IL-36 improves the IBD https://t.co/Cr3bSsDIJk
  4. Opioid Use Increases the Risk of Hospitalized Infections in RA. https://t.co/OycGF5BIGP
  5. Myelodysplasia is associated with a  29% risk of developing autoimmune disease. Most common are: hypothyroid, ITP, RA, psoriasis.  Better survival, less AML transformation when autoimmune disease is present.  https://t.co/exNy6kyQUX
  6.  21% of spondyloarthritis patients have secondary fibromyalgia (and only 30% of these were women). FM-SpA patients, not surprisingly, had more depression, psychotropics, opioid use https://t.co/E6PrRBNajI
  7. Hidradenitis suppurativa is associated with higher rates of cardiovascular events and all-cause mortality.
  8. Increasing Ultrasound training is provided in 90% of US Rheumatology Fellowships
  9. Review of lectures at RWCS.com – Check out R-W-C-S.com

 

ADD THE FIRST COMMENT

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

Disclosures
The author has no conflicts of interest to disclose related to this subject
Dr. Cush is the Executive Editor of RheumNow.com and also Co-Edits the online textbook RheumaKnowledgy.com. 
  
Dr. Cush's interests include medical education, novel drug development, rheumatoid arthritis, spondyloarthritis, drug safety, and Still's disease/autoinflammatory syndromes. He has published over 140 articles and 2 books in rheumatology.
 
He can be followed on twitter: @RheumNow